ไตรเมทิลเอมีนเอ็นออกไซด์
บทคัดย่อ
No available
References
Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, Geisel J. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids,
and methyl metabolism. Am J Clin Nutr 2016;103(3):703-11.
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19(5):576-85.
Wilson A, McLean C, Kim RB. Trimethylamine-Noxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis. Curr Opin Lipidol 2016;27(2):148-54.
Chhibber-Goel J, Gaur A, Singhal V, Parakh N, Bhargava B, Sharma A. The complex metabolism of trimethylamine in humans: endogenous and exogenous
sources. Expert Rev Mol Med 2016;29;18:e8.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472(7341):57-63.
Bäckhed F. Meat-metabolizing bacteria in atherosclerosis. Nat Med 2013;19(5):533-4.
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, R_ber L, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic
marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J 2017;38(11): 814-24.
Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes
to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116(3):448-55.
Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol JASN 2016; 27(1):305-13.
Shafi T, Powe NR, Meyer TW, Hwang S, Hai X,Melamed ML, et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol JASN 2017;28(1):321-31.
Randrianarisoa E, Lehn-Stefan A, Wang X, Hoene M, Peter A, Heinzmann SS, et al. Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early
Atherosclerosis in Humans. Sci Rep 2016;6:26745.
Senthong V, Li XS, Hudec T, Coughlin J, Wu Y, Levison B, et al. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite,
Is Associated With Atherosclerotic Burden. J Am Coll Cardiol 2016;67(22):2620-8.
Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine- N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med 2015;277(6):717-26.
Moraes C, Fouque D, Amaral ACF, Mafra D. Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet. J Ren Nutr
Off J Counc Ren Nutr Natl Kidney Found 2015;25(6): 459-65.
Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF, Yan J, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among
healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.Mol Nutr Food Res 2017;61(1).
Miller CA, Corbin KD, da Costa K-A, Zhang S, Zhao X, Galanko JA, et al. Effect of egg ingestion on trimethylamine- N-oxide production in humans: a randomized,
controlled, dose-response study1234. Am J Clin Nutr 2014;100(3):778-86.
Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl
J Med 2013;368(17):1575-84.
DiMarco DM, Missimer A, Murillo AG, Lemos BS, Malysheva OV, Caudill MA, et al. Intake of up to 3 Eggs/Day Increases HDL Cholesterol and Plasma
Choline While Plasma Trimethylamine-N-oxide is Unchanged in a Healthy Population. Lipids 2017; 52(3):255-63.
Barrett EL, Kwan HS. Bacterial reduction of trimethylamine oxide. Annu Rev Microbiol 1985;39:131-49.
Chen M, Yi L, Zhang Y, Zhou X, Ran L, Yang J, et al. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating
TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. mBio 2016;7(2): e02210-15.
Kuka J, Liepinsh E, Makrecka-Kuka M, Liepins J, Cirule H, Gustina D, et al. Suppression of intestinal microbiota-dependent production of pro-atherogenic
trimethylamine N-oxide by shifting L-carnitine microbial degradation. Life Sci 2014;117(2):84-92.
Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell 2015;163(7):1585-95.
Shih DM, Wang Z, Lee R, Meng Y, Che N, Charugundla S, et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res 2015; 56(1):22-37.
Velasquez MT, Ramezani A, Manal A, Raj DS. Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins 2016;8(11).
Downloads
เผยแพร่แล้ว
How to Cite
ฉบับ
บท
License
เนื้อหาและข้อมูลในบทความที่ตีพิมพ์ลงใน Thai JPEN วารสารโภชนบำบัด ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสารไม่จำเป็นต้องเห็นด้วยหรือร่วมรับผิดชอบใด ๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ใน Thai JPEN วารสารโภชนบำบัด ถือเป็นลิขสิทธิ์ของ Thai JPEN วารสารโภชนบำบัด หากบุคคลหรืหน่วยงานใดต้องการนำทั้งหมดหรือส่วนใดส่วนหนึ่งไปเผยแพร่หรือเพื่อกระทำการใด จะต้องได้รับอนุญาตเป็นลายลักษณ์อักษรจาก Thai JPEN วารสารโภชนบำบัด ก่อนเท่านั้น
